Expressions of cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder: Crucial role of arachidonate metabolism in tumor growth and progression

Clinical Cancer Research

Volumn 8, Issue 4, 2002, Pages 1157-1167

  Asano, Toru ^a   Shoda, Junichi ^a   Ueda, Tetsuya ^a,b   Kawamoto, Toru ^a   Shimonishi, Manabu ^c   Tanabe, Tadashi ^c   Sugimoto, Yukihiko ^d   Ichikawa, Atsushi ^d   Mutoh, Michihiro ^a   Tanaka, Naomi ^a   Miwa, Masanao ^a,e  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b LSI MEDIENCE CORPORATION   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2;

ADVANCED CANCER; ARACHIDONIC ACID METABOLISM; ARTICLE; CHOLELITHIASIS; CHRONIC INFLAMMATION; COLONY FORMATION; CONTROLLED STUDY; GALLBLADDER CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ONCOGENE C FOS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH;

AGED; ARACHIDONIC ACID; CELL DIVISION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; DISEASE PROGRESSION; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0036554862     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Rückert, J. C. R., Rückert, R. I., Gellert, K., Hecker, K., and Muller, J. M. Surgery for carcinoma of the gallbladder. Hepatogastroenterology, 43: 527-533, 1996.
2. Cubertafond, P., Gainnant, A., and Cucchiaro, G. Surgical treatment of 724 carcinomas of the gallbladder. Results of the French Surgical Association Surgery. Ann. Surg., 219: 275-280, 1994.
3. Oertli, D., Herzog, U., and Tondelli, P. Primary carcinoma of the gallbladder: operative experience during a 16-year period. Eur. J. Surg., 159: 415-420, 1993.
4. Gall, F. P., Kockerling, F., Scheele, J., Schneider, C., and Hohenberger, W. Radical operations for carcinoma of the gallbladder: present status in Germany. World J. Surg., 15: 328-336, 1991.
5. Donohue, J. H., Nagorney, D. M., Grant, C. S. Tsushima, K., Ilstrup, D. M., and Adson, M. N., Carcinoma of the gallbladder. Does radical resection improve outcome? Arch. Surg., 125: 237-241, 1990.
6. White, K., Kraybill, W. G., and Lopez, M. J. Primary carcinoma of the gallbladder. TNM staging and prognosis. J. Surg. Oncol., 39: 251-255, 1998.
7. Henson, D. E., Albores-Saavedra, J., and Corle, D. Carcinoma of the gallbladder, Histologic types, stage of disease, grade, and survival rates. Cancer (Phila.), 70: 1493-1497, 1992.
8. Ouchi, K., Owada, Y., Matsuno, S., and Sato, T. Prognostic factors in the surgical treatment of gallbladder carcinoma. Surgery, 101: 731-737, 1987.
9. Lowenfels, A. B., Lindstrom, C. G., Conway, M. J., and Hastings, P. R. Gallstones and risk of gallbladder cancer. J. Natl. Cancer Inst. (Bethesda), 75: 77-80, 1985.
10. Iwai, N., Yanagihara, J., Tokiwa, K., Shimotake, T., and Nakamura, K. Congenital choledochal dilatation with emphasis on pathophysiology of the biliary tract. Ann. Surg., 215: 27-30, 1992.
11. Tanaka, K., Nishimura, A., Yamada, K., Ishibe, R., Ishizaki, N., Yoshimine, M., Hamada, N., and Taira, A. Cancer of the gallbladder associated with anomalous junction of the pancreatobiliary duct system without bile dilation. Br. J. Surg., 80: 622-624, 1993.
12. Alobores-Saavedra, J., and Henson, D. E. Malignant tumors of the gallbladder. In: W. H. Hartmann (ed.), Tumors of the Gallbladder and Extrahepatic Bile Ducts, pp. 28-123. Armed Forces Institute of Pathology, Washington D.C., 1986.
13. Neoptolemos, J. P., Husband, D., Imaray, C., Rowley, S., and Lawson, N. Arachidonic acid and docosahexaenoic acid are increased in human colorectal cancer. Gut, 32: 278-281, 1991.
14. Bennett, A., Del Tacca, M., Stamford, I. F., and Zebro, T. Prostaglandins from tumors of human large bowel. Br. J. Cancer, 35: 881-884, 1977.
15. 2 by tissue-fixed macrophages in colonic carcinoma. Digestion, 47: 160-166, 1990.
16. Dubois, R. N., Awad, J., Morrow, J., Roberts, L. J., and Bishop, P. R. Regulation of eicosanoid production and mitogenesis in rat epithelial cells by transforming growth factor-a and phorbol esters. J. Clin. Investig., 93: 493-498, 1994.
17. Dubois, R, N., Tsujii, M., Bishop, P., Awad, J. A., Makita, K., and Lanahan, A. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am. J. Physiol., 266: G822-G827, 1994.
18. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo. J. Exp. Med., 184: 883-891, 1996.
19. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
20. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and Dubois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
21. Kutchera, W., Jones, D. A., Matsunami, N., Groden, J., McIntyre, T. M., Zimmerman, G. A., White, R. L., and Prescott, S. M. Prostaglandin H synthetase-2 is expressed abnormally in human colorectal cancer: evidence for a transcriptional effect. Proc. Natl. Acad. Sci. USA, 93: 4816-4829, 1996.
22. Kargman, S., O' Neill, G., Vickers, P., Evans, J., Mancini, J., and Jothy, S. Expression of prostaglandin G/H synthetase-1 and -2 protein in human colon cancer. Cancer Res., 55: 2556-2559, 1995.
23. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and HLa, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
24. Tsujii, M., Kawano, S., and Dubois, R. N. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl. Acad. Sci. USA, 94: 336-3340, 1997.
25. Fujita, T., Matsui, M., Takaku, K., Uetake, H., Ichikawa, W., and Taketo, M. M. Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res., 58: 4823-4826, 1998.
26. 2 in malignant and non-malignant human gastric mucosa. Br. J. Cancer, 68: 103-111, 1993.
27. 2 in human breast cancer tissues is closely associated with their malignant potency. Br. J. Cancer, 69: 1166-1170, 1994.
28. 2 in human hepatocellular carcinoma. Biochem. Biophys. Acta, 1226: 201-205, 1993.
29. 1 on gastric secretion and ulcer formation in the rat. Gastroenterology, 55: 481-487, 1979.
30. Eberhart, C. E., and Duboi, R. N. Eicosanoids and the gastrointestinal tract. Gastroenterology, 109: 285-301, 1995.
31. 2 have a synergistic role in rescuing epithelial barrier function in porcine ileum. J. Clin. Investig., 100: 1928-1933, 1997.
32. Ding, M., Kinoshita, Y., Kishi, K., Nakata, H., Hassan, S., Kawanami, C., Sugimoto, Y., Katsuyama, M., Negishi, M., Narumiya, S., Ichikawa, A., and Chiba, T. Distribution of prostaglandin E receptors in the rat gastrointestinal tract. Prostaglandins, 53: 199-216, 1997.
33. Moromoto, K., Sugimoto, Y., Katsuyama, M., Oida, H., Tsuboi, K., Kishi, K., Kinoshita, Y., Negishi, M., Chiba, T., Narumiya, S., and Ichikawa, A. Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am. J. Physiol., 272: G681-G687, 1997.
34. Fleming, I. D., Cooper, J. S., Henson, D. E., Hutter, R. V., Kennedy, B. J., Murphy, G. P., O'Sullivan, B., Sobin, L. H., and Yarbro, J. W. (eds.). AJCC Cancer Staging Manual, Ed. 5. Philadelphia: Lippincott-Raven, 1997.
35. DuBois, R. N., Shao, J., Sheng, H., Tsujii, M., and Beauchamp, R. D. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res., 56: 733-737, 1996.
36. Knuth, A., Gabbert, H., Dippold, W., Klein, O., Sachsse, W., Bitter-Suermann, D., Prellwitz, W., and Meyer zum Büschenfelde, K. H. Biliary adenocarcinoma characterization of three new human tumor cell lines. J. Hepatol., 1: 579-596, 1985.
37. Hida, T., Yatabe, Y., Achiwa, H., Muramatsu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specially in adenocarcinoma. Cancer Res., 58: 3761-3764, 1998.
38. 2. Jpn. J. Clin. Chem., 22: 180-184, 1993.
39. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193: 265-275, 1951.
40. Reed, M. K., Taylor, B., and Myers, S. I. The effect of hypoxia on rat splanchinic prostanoid output. Prostaglandins, 38: 599-608, 1989.
41. Chomczynski, P., and Sacchi, N. Single step method for RNA isolation by acid guanidinium thioctanaic-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
42. Yokoyama, C., and Tanabe, T. Cloning of human gene encoding prostaglandin endoperoxide synthetase and primary structure of the enzyme. Biochem. Biophys. Res. Commun., 165: 888-894, 1989.
43. Kasaka, T., Miyata, A., Ihara, H., Hara, S., Sugimoto, T., Takeda, O., Takahashi, E., and Tanabe, T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthetase 2. Eur. J. Biochem., 221: 889-897, 1994.
44. 2. J. Biol. Chem., 264: 5768-5775, 1989.
45. 1 subtype. J. Biol. Chem., 268: 26767-26772, 1993.
46. 2 subtype. Mol. Pharmacol., 48: 213-220, 1994.
47. 2. Eur. J. Biochem., 228: 23-30, 1995.
48. 2 subtype. J. Biol. Chem., 269: 11873-11877, 1994.
49. Sugimoto, Y., Namba, T., Shigemoto, R., Negishi, M., Ichikawa, A., and Narumiya, S. Distinct cellular localization of mRNAs for three subtypes of prostaglandin E receptor in kidney. Am. J. Physiol., 266: F823-F828, 1994.
50. Nanayama, T., Hara, S., Inoue, H., Yokoyama, C., and Tanabe, T. Regulation of two isozymes of prostaglandin endoperoxide synthetase and thromboxane synthetase in human monoblastoid cell line U937. Prostaglandins, 49: 371-382, 1995.
51. 2 in human colon cancer cells. Cancer Res., 58: 362-366, 1998.
52. 4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology, 141: 1554-1559, 2000.
53. Lau, L. F., and Nathans, D. Expression of a set of growth-related immediate early genes in BALB/c 3T3 cells: coordinate regulation with c-fos or c-myc, Proc. Natl. Acad. Sci. USA, 84: 1182-1186, 1987.
54. 2 and the protein kinase. A pathway mediate arachidonate acid induction of c-fos in human prostate cancer cells. Br. J. Cancer, 82: 2000-2006, 2000.
55. Parker, J., Kaplon, M. K., Alvarez, C. J., and Krishnaswamy, G. Prostaglandin H synthase Expression is variable in human colorectal adenocarcinoma cell lines. Exp. Cell Res., 236: 321-329, 1997.
56. Ristimaki, A., Honkanen, N., Jankala, H., Sipponen, P., and Harkonen, M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res., 57: 1276-1280, 1997.
57. Bamba, H., Ota, S., Kato, A., Adachi, A., Itoyama, S., and Matsuzaki, F. High expression of cyclooxygenase-2 in macrophages of human colonic adenoma. Int. J. Cancer, 83: 470-475, 1999.
58. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
59. Hull, M. A., Booth, J. K., Tisbury, A., Scott, N., Bonifer, C., Markham, A. F., and Coletta, P. L. Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice. Br. J. Cancer, 79: 1399-1405, 1999.
60. Shattuck-Brandt, R. L., Varilek, G. W., Radhika, A., Yang, F., Washington, M. K., and DuBois, R. N. Cyclooxygenase 2 expression is increased in the stroma of colon carcinomas from IL-10-/- mice. Gastroenterology, 118: 337-345, 2000.
61. 2 and diacylglycerol lipase are increased in human colorectal cancer. Br. J. Surg., 82: 475-478, 1995.
62. 2 in Swiss 3T3 cells via specific binding site. J. Biol. Chem., 266: 19139-19141, 1991.
63. 2 expression and prostaglandin biosynthesis in rat mesangial cells. J. Biol. Chem., 269: 5092-5098, 1994.
64. Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Schiff, S. J., and Rigas, B. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol., 52: 237-245, 1996.
65. Hong, W. K., and Sporn, M. B. Recent advances in chemoprevention of cancer. Science (Wash. DC), 278: 1073-1077, 1997.
66. Noran, R. D., Danilowiez, R. M., and Eling, T. E. Role of arachidonic acid metabolism in mitogenic response of BALB/c 3T3 fibroblasts to epidermal growth factor. Mol. Pharmacol., 33: 650-656, 1988.
67. 2-mediated suppression of cellular immunity in colon cancer patients. Surgery, 95: 71-77, 1984.
68. Brunda, M. J., Herberman, R. B., and Holden, H. T. Inhibition of murine natural killer cell activity by prostaglandins. J. Immunol., 124: 2682-2688, 1980.
69. Hla, T., Ristimaki, A., Appleby, S., and Barriocanal, J. G. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann. N. Y. Acad. Sci., 686: 197-204, 1993.
70. Ziche, M., Jones, J., and Gullino, P. M. Role of prostaglandin E1 and copper in angiogenesis. J. Natl. Cancer Inst. (Bethesda), 6: 475-482, 1982.
71. Ota, S., Tanaka, Y., Bamba, H., Kato, A., and Matsuzaki, F. Nonsteroidal anti-inflammatory drugs may prevent colon cancer through suppression of hepatocyte growth factor expression. Eur. J. Pharmacol., 367: 131-138, 1999.
72. Grossman, E. M., Longo, W. E., Panesar, N., Mazuski, J. E., and Kaminski, D. L. The role of cyclooxygenase enzymes in the growth of human gallbladder cancer cells. Carcinogenesis, 21: 1403-1409, 2000.
73. Takeuchi, K., Yagi, K., Kato, S., and Ukawa, H. Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats. Gastroenterology, 113: 1553-1559, 1997.
74. 2+/nitric oxide/cGMP pathway. J. Biol. Chem., 270: 18781-18785, 1995.
75. 4 receptor. Gastroenterology, 117: 1352-1362, 1999.
76. 2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem., 276: 18075-18081, 2001.
77. 2 in human prostatic carcinoma cells. Br. J. Cancer, 75: 1111-1118, 1997.